India seeks details of Uzbekistan's investigation into cough syrup deaths case
New Delhi: India is in touch with the Uzbak authorities and has sought details of their investigation into the death of 18 children after allegedly consuming cough syrup made by an Indian firm, the External Affairs Ministry said on Thursday. MEA spokesperson Arindam Bagchi also said consular assistance is being provided to some linked to the company who are facing legal action there.
"There is no problem from our end and no issue in testing. We have been theree for the past ten years. Once the government report will come, we will look into it. For now the manufacturing has stopped," Hasan Harris, legal representative of Marion Biotech told PTI.
Marion Biotech, does not sell cough syrup, 'Doc-1 Max', in India, and its only export has been to Uzbekistan.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.